AN IMMUNOCHEMICAL ANALYSIS OF THE HUMAN NUCLEAR PHOSPHOPROTEIN-P53 - NEW MONOCLONAL-ANTIBODIES AND EPITOPE MAPPING USING RECOMBINANT-P53

被引:583
作者
VOJTESEK, B
BARTEK, J
MIDGLEY, CA
LANE, DP
机构
[1] UNIV DUNDEE, CANC RES CAMPAIGN LABS, DEPT BIOCHEM, DUNDEE DD1 4HN, SCOTLAND
[2] INST HEMATOL & BLOOD TRANSFUS, PRAGUE 10, CZECHOSLOVAKIA
关键词
IMMUNOCHEMICAL ANALYSIS; NUCLEAR PHOSPHOPROTEIN P53; MONOCLONAL ANTIBODY; EPITOPE MAPPING;
D O I
10.1016/0022-1759(92)90122-A
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Somatic mutation of the p53 gene is a very frequent event in the development of human neoplasia, and germ line mutations in p53 are responsible for an inherited cancer susceptibility syndrome. Many of the mutations in p53 found in human tumours are point mutations that result in the substitution of a single amino acid in the protein. These point mutant proteins are much more stable than the normal protein and the mutant product accumulates to a high level which permits important information about p53 expression to be obtained by immunochemical analysis. Using bacterial expression systems to produce fragments of human p53 we have isolated and characterised new monoclonal antibodies to p53. These antibodies are suitable for the measurement of p53 in ELISA, immunoblotting and immunoprecipitation analyses. They are especially useful in immunohistochemistry as they are able to react strongly with p53 in conventionally fixed and processed histological sections.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 24 条
  • [11] P53 IMMUNOSTAINING AS A MARKER OF MALIGNANT DISEASE IN DIAGNOSTIC CYTOPATHOLOGY
    HALL, PA
    RAY, A
    LEMOINE, NR
    MIDGLEY, CA
    KRAUSZ, T
    LANE, DP
    [J]. LANCET, 1991, 338 (8765) : 513 - 513
  • [12] MONOCLONAL-ANTIBODIES SPECIFIC FOR SIMIAN VIRUS-40 TUMOR-ANTIGENS
    HARLOW, E
    CRAWFORD, LV
    PIM, DC
    WILLIAMSON, NM
    [J]. JOURNAL OF VIROLOGY, 1981, 39 (03) : 861 - 869
  • [13] HARLOW E, 1988, ANTIBODIES LABORATOR
  • [14] MUTATION IS REQUIRED TO ACTIVATE THE P53 GENE FOR COOPERATION WITH THE RAS ONCOGENE AND TRANSFORMATION
    HINDS, P
    FINLAY, C
    LEVINE, AJ
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (02) : 739 - 746
  • [15] INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER
    IGGO, R
    GATTER, K
    BARTEK, J
    LANE, D
    HARRIS, AL
    [J]. LANCET, 1990, 335 (8691) : 675 - 679
  • [16] P53 - ONCOGENE OR ANTI-ONCOGENE
    LANE, DP
    BENCHIMOL, S
    [J]. GENES & DEVELOPMENT, 1990, 4 (01) : 1 - 8
  • [17] THE P53 TUMOR SUPPRESSOR GENE
    LEVINE, AJ
    MOMAND, J
    FINLAY, CA
    [J]. NATURE, 1991, 351 (6326) : 453 - 456
  • [18] MIDGLEY CA, 1992, J CELL SCI, V101, P183
  • [19] POST-TRANSLATIONAL REGULATION OF THE 54K CELLULAR TUMOR-ANTIGEN IN NORMAL AND TRANSFORMED-CELLS
    OREN, M
    MALTZMAN, W
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1981, 1 (02) : 101 - 110
  • [20] REIHSAUS E, 1990, ONCOGENE, V5, P137